| Kayalvizhi Sambandam, MD | |
|
600 Coffee Rd, Modesto, CA 95355-4201 | |
| (209) 521-6097 | |
| Not Available |
| Full Name | Kayalvizhi Sambandam |
|---|---|
| Gender | Female |
| Speciality | Pulmonary Disease |
| Experience | 37 Years |
| Location | 600 Coffee Rd, Modesto, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801820014 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Medical Center | Modesto, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Valley Medical Foundation | 9830094515 | 1840 |
News Archive
GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.
Infants exposed to rodent and pet dander, roach allergens and a wide variety of household bacteria in the first year of life appear less likely to suffer from allergies, wheezing and asthma, according to results of a study conducted by scientists at the Johns Hopkins Children's Center and other institutions.
Research by scientists at the University of York has revealed important new information about the dynamics of bacterial gels which could ultimately suggest new ways of helping prevent or better control diseases such as cystic fibrosis.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
› Verified 7 days ago
| Entity Name | Sutter Valley Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669846986 PECOS PAC ID: 9830094515 Enrollment ID: O20090311000335 |
News Archive
GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.
Infants exposed to rodent and pet dander, roach allergens and a wide variety of household bacteria in the first year of life appear less likely to suffer from allergies, wheezing and asthma, according to results of a study conducted by scientists at the Johns Hopkins Children's Center and other institutions.
Research by scientists at the University of York has revealed important new information about the dynamics of bacterial gels which could ultimately suggest new ways of helping prevent or better control diseases such as cystic fibrosis.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kayalvizhi Sambandam, MD 600 Coffee Rd, Modesto, CA 95355-4201 Ph: (209) 521-6097 | Kayalvizhi Sambandam, MD 600 Coffee Rd, Modesto, CA 95355-4201 Ph: (209) 521-6097 |
News Archive
GENova Biotherapeutics, Inc., ("GENova") - (OTCBB: GVBP.OB), a biotechnology company that identifies, acquires, and develops novel drug targets that disrupt the advance of life-threatening diseases, today named Aaron Whiteman as its Chief Executive Officer.
Infants exposed to rodent and pet dander, roach allergens and a wide variety of household bacteria in the first year of life appear less likely to suffer from allergies, wheezing and asthma, according to results of a study conducted by scientists at the Johns Hopkins Children's Center and other institutions.
Research by scientists at the University of York has revealed important new information about the dynamics of bacterial gels which could ultimately suggest new ways of helping prevent or better control diseases such as cystic fibrosis.
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Tuesday published Issue 208 of its "Global Fund Observer." Among others, the issue contains two stories on the new funding model (NFM), which, according to the first article, the Global Fund to Fight AIDS, Tuberculosis and Malaria expects to launch by the end of February.
› Verified 7 days ago
Brian E. Dolnick, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-557-1000 | |
Dr. Joshua Mckee Anderson, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 4601 Dale Rd, Modesto, CA 95356 Phone: 209-735-7200 | |
Sulman Razzaq, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1409 E Briggsmore Ave, Modesto, CA 95355 Phone: 209-550-4750 | |
Alvin K Eng, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1540 Florida Ave, # 100, Modesto, CA 95350 Phone: 209-577-5557 Fax: 209-577-8125 | |
Esra Olgun, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-521-6097 | |
Ronak Chandrakant Shah, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 600 Coffee Rd, Modesto, CA 95355 Phone: 209-521-6097 | |
Dr. Paul Golden, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1330 Nelson Ave, Suite C, Modesto, CA 95350 Phone: 209-576-1547 Fax: 209-576-2736 |